Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Plus Therapeutics Inc.

    NASDAQ: PSTV · Real-Time Price · USD
    0.34
    0.01 (4.45%)
    At close: Jun 09, 2025, 3:59 PM

    Plus Therapeutics Statistics

    Share Statistics

    Plus Therapeutics has 32.72M shares outstanding. The number of shares has increased by 106.6% in one year.

    Shares Outstanding

    n/a
    		 32.72M

    Shares Change (YoY)

    n/a
    		 106.6%

    Shares Change (QoQ)

    n/a
    		 99.87%

    Owned by Institutions (%)

    n/a
    		 11.5%

    Shares Floating

    n/a
    		 29.81M

    Failed to Deliver (FTD) Shares

    n/a
    		 262,827

    FTD / Avg. Volume

    n/a
    		 1.76%

    Short Selling Information

    The latest short interest is 3.49M, so 59.18% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 3.49M

    Short % of Shares Out

    n/a
    		 59.18%

    Short % of Float

    n/a
    		 60.31%

    Short Ratio (days to cover)

    n/a
    		 1.77

    Valuation Ratios

    The PE ratio is -5.88 and the forward PE ratio is -0.41. Plus Therapeutics's PEG ratio is 0.06.

    PE Ratio

    n/a
    		 -5.88

    Forward PE

    n/a
    		 -0.41

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 0.1

    PB Ratio

    n/a
    		 -8.53

    P/FCF Ratio

    n/a
    		 -6.79

    PEG Ratio

    n/a
    		 0.06
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Plus Therapeutics.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 0.34, with a Debt / Equity ratio of -0.38.

    Current Ratio

    n/a
    		 0.34

    Quick Ratio

    n/a
    		 0.34

    Debt / Equity

    n/a
    		 -0.38

    Debt / EBITDA

    n/a
    		 -0.4

    Debt / FCF

    n/a
    		 -0.3

    Interest Coverage

    n/a
    		 -3.95

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $277,333.33

    Profits Per Employee

    n/a
    		 $-618,000

    Employee Count

    n/a
    		 21

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -85.96% in the last 52 weeks. The beta is 0.88, so Plus Therapeutics's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.88

    52-Week Price Change

    n/a
    		 -85.96%

    50-Day Moving Average

    n/a
    		 0.63

    200-Day Moving Average

    n/a
    		 1.1

    Relative Strength Index (RSI)

    n/a
    		 38.76

    Average Volume (20 Days)

    n/a
    		 14,967,190

    Income Statement

    In the last 12 months, Plus Therapeutics had revenue of 5.82M and earned -12.98M in profits. Earnings per share was -1.95.

    Revenue

    n/a
    		 5.82M

    Gross Profit

    n/a
    		 4.97M

    Operating Income

    n/a
    		 -14.7M

    Net Income

    n/a
    		 -12.98M

    EBITDA

    n/a
    		 -8.4M

    EBIT

    n/a
    		 -9.25M

    Earnings Per Share (EPS)

    n/a
    		 -1.95
    Full Income Statement

    Balance Sheet

    The company has 76K in cash and 3.37M in debt, giving a net cash position of -3.29M.

    Cash & Cash Equivalents

    n/a
    		 76K

    Total Debt

    n/a
    		 3.37M

    Net Cash

    n/a
    		 -3.29M

    Retained Earnings

    n/a
    		 -493.48M

    Total Assets

    n/a
    		 6.63M

    Working Capital

    n/a
    		 -10.29M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -10.55M and capital expenditures -146K, giving a free cash flow of -11.24M.

    Operating Cash Flow

    n/a
    		 -10.55M

    Capital Expenditures

    n/a
    		 -146K

    Free Cash Flow

    n/a
    		 -11.24M

    FCF Per Share

    n/a
    		 -0.17
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 -252.32%

    FCF Margin

    n/a
    		 -193.08%

    Dividends & Yields

    PSTV does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for PSTV is $13, which is 3839.4% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $13

    Price Target Difference

    n/a
    		 3839.4%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 3
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on May 1, 2023. It was a backward split with a ratio of 1:15.

    Last Split Date

    n/a
    		 May 1, 2023

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:15

    Scores

    Altman Z-Score

    n/a
    		 -111.75

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist